$157M
$107,000
0.0% of portfolio
23,296
Q4 2024
Added 24.35%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 35.74%
$1.19B
$2.14 Million
0.0% of portfolio
26,911
Q4 2024
Added 5.75%
$280M
$530,000
0.0% of portfolio
10,354
Q4 2024
Added 124.94%
$5.97B
$1.9 Million
0.0% of portfolio
88,590
Q4 2024
Reduced 43.58%
$845M
$1.32 Million
0.0% of portfolio
30,133
Q4 2024
Added 22.86%
$168M
$111,000
0.0% of portfolio
6,791
Q4 2024
Added 4.01%
$2.56B
$5.3 Million
0.0% of portfolio
562,333
Q4 2024
Added 74.18%
$5.32B
$3.44 Million
0.0% of portfolio
133,776
Q4 2024
Added 14.71%
$1.29B
$1.37 Million
0.0% of portfolio
173,115
Q4 2024
Added 13.55%
$38.8M
$3,000
0.0% of portfolio
1,514
Q3 2024
Reduced 50.0%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 31.73%
$1.57B
$2.35 Million
0.0% of portfolio
63,171
Q4 2024
Added 9.27%
$0
$10,000
0.0% of portfolio
170
Q4 2023
Reduced 78.75%
-
$0
0.0% of portfolio
-
Q1 2024
New
$0
$95,000
0.0% of portfolio
2,200
Q3 2024
Reduced 8.33%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 7.74%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 22.43%
$0
$6,000
0.0% of portfolio
750
Q1 2023
Reduced 50.0%
$186M
$190,000
0.0% of portfolio
31,714
Q4 2024
Added 6.83%
$849M
$700,000
0.0% of portfolio
66,419
Q4 2024
Added 19.79%
$277M
$43,000
0.0% of portfolio
15,508
Q4 2024
Added 29.85%
$129M
$239,000
0.0% of portfolio
7,631
Q4 2024
Added 242.2%
$179M
$2.3 Million
0.0% of portfolio
609,324
Q4 2024
Added 5.97%
-
$0
0.0% of portfolio
-
Q4 2024
Added 249.18%
$623M
$1 Million
0.0% of portfolio
93,477
Q4 2024
Added 53.75%
$1.49B
$1.94 Million
0.0% of portfolio
47,892
Q4 2024
Added 2.94%
$248M
$87,000
0.0% of portfolio
9,439
Q4 2024
Added 2.7%
$386M
$278,000
0.0% of portfolio
30,385
Q4 2024
Added 7.39%
$111B
$2.33 Million
0.0% of portfolio
46,605
Q4 2024
Reduced 55.19%
$259M
$168,000
0.0% of portfolio
10,228
Q4 2024
Reduced 11.24%
Annaly Capital Management In
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 59.1%
$123M
$865,000
0.0% of portfolio
168,787
Q4 2024
Added 141.1%
$11.2B
$4.65 Million
0.0% of portfolio
132,603
Q4 2024
Reduced 25.53%
$7.6B
$1.21 Million
0.0% of portfolio
80,429
Q4 2024
Reduced 88.01%
$710M
$269,000
0.0% of portfolio
8,771
Q4 2024
Added 0.15%
$1.36B
$1.13 Million
0.0% of portfolio
124,170
Q4 2024
Added 13.63%
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 98.81%
$2.96B
$6.13 Million
0.0% of portfolio
192,161
Q4 2024
Added 1,480.01%
$1.08B
$2.29 Million
0.0% of portfolio
32,072
Q4 2024
Added 3.65%
$893M
$57,000
0.0% of portfolio
5,192
Q4 2024
Added 27.35%
$1.42B
$1.61 Million
0.0% of portfolio
185,817
Q4 2024
Added 3.01%
$1.66B
$2.21 Million
0.0% of portfolio
60,175
Q4 2024
Added 7.83%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 62.37%
-
$0
0.0% of portfolio
-
Q4 2024
Added 99.41%
$1.37B
$1.56 Million
0.0% of portfolio
47,349
Q4 2024
Added 6.17%
$4.26B
$2.27 Million
0.0% of portfolio
9,191
Q4 2024
Added 14.03%